Through robust processes and internal protocols, we develop products as per the most stringent ICH guidelines. Ensuring our partners can register the products across markets with ease.
PRODUCT NAME | PHARMACOPEIA | DMF | CEP Status |
---|---|---|---|
Nilotinib HCl Monohydrate | EP | ||
Gemcitabine HCl | IP / EP / USP | ||
Pemetrexed Disodium Heptahydrate | IP / EP / USP | ||
Methotrexate | IP /BP/ EP / USP | ||
Palbociclib | IH | ||
Pazopanib HCl | IH | ||
Enzalutamide | IH | ||
Bendamustine HCl | IP / USP | ||
Methotrexate Disodium | IH |
Discalimer
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and liability for infringement is exclusively understood at buyer’s risk.